论文部分内容阅读
In 2018,merely breast cancer occupies 30%of all cancers expected to occur in women.However,tumor metastasis is one of the main reasons for poor tumor efficacy,especially for triple-negative breast cancer cell lines(TNBC).Thus,how to find effective biomarkers to track the metastatic development of breast cancer has been a hot topic.